Vasca raises $20 million for breakthrough product
This article was originally published in Clinica
Vasca, which claims to have developed the first major advance in dialysis access in a decade, has raised nearly $20 million in private equity financing. The round was led by MVM, a UK-based medical venture fund. MVM's CEO, Stephen Reeders, will join the company's board.